Travere Therapeutics (TVTX) Return on Assets [ROA] (2011 - 2026)
Travere Therapeutics' Return on Assets [ROA] was -6.42% in Q2 2026, up 24.21 percentage points from -30.63% a year earlier but down 2.73 percentage points from the prior quarter.
Travere Therapeutics (TVTX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Travere Therapeutics came in at -4.26%, up 42.24 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +23.69 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -46.50% in FY2024 (-31.25 pp), -15.24% in FY2023 (+23.19 pp), -38.43% in FY2022 (-12.41 pp) and -26.02% in FY2021 (+1.93 pp).
- Quarterly Return on Assets [ROA] has moved between -66.60% (Q3 2024) and -3.69% (Q1 2026) over five years.
- Compared with a year earlier, Return on Assets [ROA] has increased for four straight quarters, with an average year-over-year change of +5.03 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2025 (a gain of 54.08 percentage points); the worst was Q3 2024 (a drop of 55.51 percentage points).
- Per Business Quant data, TVTX's Return on Assets [ROA] in the three quarters before Q2 2026 was -3.69% (Q1 2026), -4.47% (Q4 2025) and -16.19% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Travere Therapeutics | 5.35 Bn | 4.95 Bn | 167.41 Mn | -6.42% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.42% |
| Mar 31, 2026 | -3.69% |
| Dec 31, 2025 | -4.47% |
| Sep 30, 2025 | -16.19% |
| Jun 30, 2025 | -30.63% |
| Mar 31, 2025 | -39.68% |
| Dec 31, 2024 | -58.55% |
| Sep 30, 2024 | -66.60% |
| Jun 30, 2024 | -24.02% |
| Mar 31, 2024 | -22.19% |
| Dec 31, 2023 | -13.74% |
| Sep 30, 2023 | -11.09% |
| Jun 30, 2023 | -39.81% |
| Mar 31, 2023 | -39.01% |
| Dec 31, 2022 | -39.82% |
| Sep 30, 2022 | -40.04% |
| Jun 30, 2022 | -33.26% |
| Mar 31, 2022 | -29.83% |
| Dec 31, 2021 | -28.01% |
| Sep 30, 2021 | -32.87% |
Travere Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();